IRIS
Perna, Giampaolo Robert
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.921
AS - Asia 5.309
EU - Europa 2.294
SA - Sud America 2.133
AF - Africa 308
Continente sconosciuto - Info sul continente non disponibili 299
OC - Oceania 14
Totale 19.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.642
SG - Singapore 2.696
BR - Brasile 1.726
CN - Cina 965
VN - Vietnam 895
IT - Italia 754
FI - Finlandia 362
IE - Irlanda 266
DE - Germania 187
NG - Nigeria 174
AR - Argentina 159
FR - Francia 157
CA - Canada 144
NL - Olanda 129
GB - Regno Unito 127
IN - India 95
HK - Hong Kong 92
TR - Turchia 83
ID - Indonesia 82
BD - Bangladesh 78
EC - Ecuador 74
RU - Federazione Russa 64
CO - Colombia 58
MX - Messico 58
IQ - Iraq 55
SE - Svezia 47
ZA - Sudafrica 45
IL - Israele 38
IR - Iran 36
PY - Paraguay 35
ES - Italia 32
CZ - Repubblica Ceca 26
UA - Ucraina 25
MA - Marocco 24
PK - Pakistan 24
CL - Cile 23
KR - Corea 23
PL - Polonia 23
SA - Arabia Saudita 20
VE - Venezuela 20
PE - Perù 19
EG - Egitto 17
CR - Costa Rica 16
JM - Giamaica 16
UY - Uruguay 15
AT - Austria 13
MY - Malesia 13
TW - Taiwan 13
AU - Australia 12
BE - Belgio 12
KE - Kenya 12
JP - Giappone 11
PT - Portogallo 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
HN - Honduras 9
NP - Nepal 9
PH - Filippine 9
TN - Tunisia 9
CH - Svizzera 7
DZ - Algeria 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
AL - Albania 6
ET - Etiopia 6
LB - Libano 6
RO - Romania 6
AZ - Azerbaigian 5
JO - Giordania 5
LT - Lituania 5
PA - Panama 5
SN - Senegal 5
TH - Thailandia 5
BO - Bolivia 4
BY - Bielorussia 4
EE - Estonia 4
GA - Gabon 4
GE - Georgia 4
GR - Grecia 4
KZ - Kazakistan 4
OM - Oman 4
RS - Serbia 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BW - Botswana 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
SV - El Salvador 2
Totale 18.964
Salva come PNG Salva come JPEG
Città #
Wilmington 1.142
Singapore 1.054
The Dalles 494
San Mateo 437
Ashburn 436
Shanghai 429
Chandler 407
Helsinki 362
San Jose 340
Ho Chi Minh City 309
Dallas 298
Milan 274
Dublin 264
Council Bluffs 253
Ann Arbor 252
Princeton 249
Leawood 237
Beijing 236
Lawrence 225
Hanoi 206
Benin City 173
Fairfield 159
New York 153
Santa Clara 145
São Paulo 145
Woodbridge 138
Rome 121
Paris 118
Los Angeles 107
Amsterdam 91
Hong Kong 84
Boardman 80
Toronto 65
London 64
Phoenix 58
Kocaeli 57
Rio de Janeiro 49
Buffalo 47
Naples 44
Da Nang 41
Bradenton 40
Brasília 39
Orem 38
Seattle 35
Belo Horizonte 33
Guayaquil 31
Haiphong 31
Chicago 30
Turin 30
Curitiba 29
Porto Alegre 29
Newark 27
Norwalk 27
Mansfield 25
Charlotte 24
Atlanta 21
Figino 21
Asunción 20
Brooklyn 20
Campinas 20
Falkenstein 20
Chennai 19
Houston 19
Munich 19
Oakland 19
Philadelphia 19
Fortaleza 18
Hải Dương 18
Miami 18
Monmouth Junction 18
Quito 18
Baghdad 17
Montreal 17
Pittsburgh 17
Thái Nguyên 17
Boston 16
Brno 16
Goiânia 16
San Diego 16
The Bronx 16
Cape Town 15
Ha Long 15
Queens 15
Ribeirão Preto 15
Salvador 15
Jakarta 14
Johannesburg 14
Lima 14
Recife 14
Warsaw 14
Biên Hòa 13
Bogotá 13
Bắc Ninh 13
Corbin 13
Guarulhos 13
Moscow 13
Ninh Bình 13
Richmond 13
Riyadh 13
Seoul 13
Totale 11.041
Salva come PNG Salva come JPEG
Nome #
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment 180
Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression 173
A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures 169
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study 160
Baseline respiratory parameters in panic disorder: A meta-analysis 156
Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition 154
Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients 147
Are Respiratory Abnormalities Specific for Panic Disorder? A Meta-Analysis 144
Approximate entropy of respiratory patterns in panic disorder 143
A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge 143
A clinically-translatable machine learning algorithm for the prediction of Alzheimer's disease conversion: further evidence of its accuracy via a transfer learning approach 142
BALANCE REHABILITATION WITH PERIPHERAL VISUAL STIMULI IN NON-RESPONDER PATIENTS WITH PANIC DISORDER AND AGORAPHOBIA: A PILOT STUDY 135
Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years 133
'Precision' or 'personalized' psychiatry: different terms - same content? 131
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder 128
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome 124
Heart rate variability: Can it serve as a marker of mental health resilience?: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD 122
The Panic Respiration Connection 121
35-PERCENT CO2 CHALLENGE IN PANIC AND MOOD DISORDERS 118
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD 117
The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after week of treatment with citalopram: An open study 117
Childhood adversities in patients with fibromyalgia: are they related to comorbid lifetime major depression? 116
A comprehensive review on the efficacy of S-adenosyl-L-Methionine in major depressive disorder 116
Acoustic startle response in panic disorder 115
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naive patients with first-episode major depression: An exploratory study in the "real world" everyday clinical practice 114
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review 112
Respiration in children at risk for panic disorder 111
ALEXITHYMIA AND ITS RELATIONSHIPS WITH ACUTE PHASE PROTEINS AND CYTOKINE RELEASE: AN UPDATED REVIEW 111
AGE AT ONSET OF PANIC DISORDER - INFLUENCE OF FAMILIAL LIABILITY TO THE DISEASE AND OF CHILDHOOD SEPARATION ANXIETY DISORDER 110
Alexithymia, suicidal ideation, and serum lipid levels among drug-naive outpatients with obsessive-compulsive disorder 109
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders 108
A Case Study of the 35% CO2 Challenge 108
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 105
The 35% CO2 challenge test in patients with social phobia 103
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 102
Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress 102
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3 101
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression 101
COVID-19 and panic disorder: clinical considerations for the most physical of mental disorders 100
A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge 100
S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study 100
Psicopatologia Funzionale 98
Childhood Trauma, Temperament, and Character in Subjects With Major Depressive Disorder and Bipolar Disorder 98
Personality biomarkers of pathological gambling: A machine learning study 97
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines 96
Is there a link between child abuse and neglect ans anxiety disorders? 96
Cardiorespiratory Assessments in Panic Disorder Facilitated by Wearable Devices: A Systematic Review and Brief Comparison of the Wearable Zephyr BioPatch with the Quark-b2 Stationary Testing System 93
CO2-induced panic attacks: A twin study 92
ALPHA(2)-ADRENERGIC RECEPTOR SENSITIVITY IN PANIC DISORDER .1. GH RESPONSE TO GHRH AND CLONIDINE STIMULATION IN PANIC DISORDER 91
Modelos explicativos de los trastornos de angustia: una perspectiva integradora 90
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice 90
ALPHA(2)-ADRENERGIC RECEPTOR SENSITIVITY IN PANIC DISORDER .2. CORTISOL RESPONSE TO CLONIDINE STIMULATION IN PANIC DISORDER 90
Il Disturbo di Panico in Infanzia 88
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 88
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: A double-blind, random, placebo-controlled study 88
Panic disorder: from respiration to the homeostatic brain 87
The revolution of personalized psychiatry: will technology make it happen sooner? 87
Panic disorder: the role of the balance system 86
An update of safety of clinically used atypical antipsychotics 86
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine 85
Clonazepam in the treatment of psychiatric disorders: an update 85
Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry 84
Biomarker-Guided Tailored Therapy in Major Depression 84
Neuroimaging in Generalized Anxiety Disorder 84
Features of mood associated with high body weight in females with fibromyalgia 84
Reduced cortical thickness and increased gyrification in generalized anxiety disorder: a 3 T MRI study 84
The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits? 84
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder 83
Cigarette smoking has no pro-cognitive effect in subjects with obsessive-compulsive disorder: A preliminary study 83
Temperament, Character and Anxiety Sensitivity in Panic Disorder: A High-Risk Study 83
Anxiety sensitivity in children of panic disorder patients 83
I Disturbi D’Ansia 83
Menstrual Cycle and 35% CO2 challenge in panic disorder: a preliminary report 83
Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review 83
Neuroprogression in anxiety disorders 82
Language of dyspnea in panic disorder 82
The role of spatial store and executive strategy in spatial working memory: a comparison between patients with obsessive-compulsive disorder and controls 82
Emerging drugs for panic disorder 82
Smoking and respiratory irregularity in panic disorder 81
Novel investigational therapeutics for panic disorder 81
C-REACTIVE PROTEIN LEVEL AND ITS RELATIONSHIP WITH SUICIDE RISK AND ALEXITHYMIA AMONG NEWLY DIAGNOSED, DRUG-NAIVE PATIENTS WITH NON-AFFECTIVE PSYCHOSIS 80
Is there cardiac risk in panic disorder? An updated systematic review 80
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study 80
Common genetic, clinical; demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 80
Short-Term Psychiatric Rehabilitation in Major Depressive and Bipolar Disorders: Neuropsychological-Psychosocial Outcomes 80
Is there a role for pharmacogenetics in the treatment of panic disorder? 79
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder 79
Cardiorespiratory response to physical exercise and psychological variables in panic disorder 79
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene 78
Self-reported quality of life and clinician-rated functioning in mood and anxiety disorders: Relationships and neuropsychological correlates 78
TEMPORAL-LOBE INVOLVEMENT IN PANIC DISORDER - RESULTS OF A REPLICATION STUDY 78
Nosografia 78
Cariprazine (RGH-188): a new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 78
Basi Biologiche e Inquadramento Clinico e Terapeutico dei Disturbi d’Ansia 77
La paura, il panico e l’ansia 77
Terapia Farmacologica della Fobia Sociale 76
Mediation effect of recent loss events on weight gain in obese people who experienced childhood parental death or separation 76
HYPERSENSITIVITY TO INHALATION OF CARBON-DIOXIDE AND PANIC ATTACKS 76
Dizziness, migrainous vertigo and psychiatric disorders 76
La rabbia e l’aggressività 75
Totale 10.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022846 0 0 0 208 13 9 46 150 86 94 219 21
2022/20231.898 477 73 259 111 103 106 19 104 231 253 146 16
2023/20241.461 135 131 269 45 27 102 83 94 32 31 205 307
2024/20252.253 38 0 19 79 23 319 107 109 290 690 277 302
2025/20267.874 864 1.030 775 1.373 260 201 1.138 417 398 325 266 827
2026/20272.467 805 372 1.100 190 0 0 0 0 0 0 0 0
Totale 19.278